SHOTUNE Knowledge Series
EU MDR and medical device regulatory insights for stronger technical and clinical decisions.
These medical device regulatory insights help regulatory, clinical, quality, and executive leaders understand how EU MDR renewal, clinical evidence, post-market obligations, certificate timing, and technical-documentation decisions connect.
Each resource moves beyond document-level compliance. The series examines the connected decisions behind technical-documentation readiness, clinical-evidence strength, product continuity, post-market obligations, and Notified Body review.
Use the resources to identify where regulatory, clinical, quality, post-market, risk, and claims conclusions may no longer align. Then bring that clearer picture into the next renewal, submission, remediation, or Notified Body response decision.
Executive resource library
Explore the medical device regulatory insights
Each resource connects a specific regulatory question to the wider portfolio, evidence, governance, and market-continuity decisions surrounding it.
PDF resource
Why EU MDR Is a Governance Challenge — Not a Documentation Exercise
See how regulatory transitions expose misalignment across clinical evidence, quality systems, post-market obligations, technical documentation, and governance.
PDF resource
Building an Integrated PMS–PMCF–CER Engine for Portfolio Growth Under EU MDR
Explore how post-market surveillance, PMCF, clinical etechnical assessment, risk management, and lifecycle evidence can operate as one continuous system.
PDF resource
EU MDR Portfolio Heatmaps: Turning Certificates and Risk into an Executive Dashboard
Learn how certificate timing, renewal waves, evidence gaps, document readiness, and product priorities can be translated into one leadership view.
PDF resource
Designing Enterprise MDR Governance: From Functional Silos to Integrated Decision Councils
Review a governance approach that brings regulatory, clinical, quality, post-market, risk, and portfolio decisions into an accountable executive structure.
PDF resource
Preventing the 2026–2027 MDR Bottleneck: Certificate Cliffs, Renewal Waves, and SKU Triage
Understand how clustered renewals, constrained review capacity, product rationalization, and delayed decisions can threaten market continuity.
EU MDR renewal and Notified Body readiness
Bring the insight into the live submission decision.
A resource can clarify the pattern. An independent readiness review can test what that pattern means across technical documentation, clinical evidence, post-market files, risk conclusions, claims, and prior findings.
Request an EU MDR readiness review
Start with the renewal timeline, known concerns, previous findings, and documents already available.